Form 4/A for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-02-17 00:00:00 ET · period of report 2021-11-30 · accession 0001437749-22-003763 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-02-17 | 2021-11-30 | BLFS | Wichterman Troy | CFO | S - Sale | $37.59 | -33 | 22.4K | -0.1% | -$1,240 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-30 | S | D | 33 | $37.59 | 22,432 | D | — | — | (F2) On December 2, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares. |